Related Experiment Video
Updated: Feb 27, 2026
03:49
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
1.3K
Methods of Hearing Preservation during Cochlear Implantation
Ahmed Khater1, Mohammad Waheed El-Anwar1
1Department of Otorhinolaryngology Head and Neck Surgery, Zagazig University, Zagazig, Egypt.
International Archives of Otorhinolaryngology
|July 7, 2017
Summary
Preserving residual hearing during cochlear implantation (CI) is increasingly possible. Soft surgery techniques, including careful electrode insertion and fluid management, aim to minimize cochlear damage and maximize hearing outcomes.
Area of Science:
- Otolaryngology
- Neurosurgery
- Biomedical Engineering
Background:
- Advances in surgical techniques and electrode design enable residual hearing preservation during cochlear implantation (CI).
- Preserving hearing is desirable for cochlear implant recipients, offering potential benefits for low-frequency hearing and future therapies.
Purpose of the Study:
- To review existing literature on methods for hearing preservation during cochlear implantation surgery.
Main Methods:
- A comprehensive literature search was conducted across LILACS, MEDLINE, SciELO, PubMed, and Cochrane Library.
- Keywords included CI, hearing preservation, CI electrode design, and CI soft surgery.
- Approximately 15 studies meeting selection criteria were fully reviewed.
Main Results:
- Factors contributing to cochlear damage include mechanical insertion trauma, fluid shock waves, acoustic trauma, perilymph loss, infection, and fibrous tissue formation.
- Soft surgery protocols aim to mitigate these risks, with evidence supporting blood avoidance and hyaluronate use, while topical steroid efficacy remains questionable.
- Key surgical factors include the cochlear entry site, electrode design, and insertion depth.
Conclusions:
- Hearing preservation in cochlear implantation allows patients to utilize residual low-frequency hearing.
- It also benefits pediatric candidates who may be eligible for future regenerative hair cell therapies.
